[NBIX] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
06-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -36.79%
YoY- 88.07%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 258,500 302,400 237,100 244,100 222,094 183,580 138,403 51.48%
PBT -57,100 83,200 38,900 38,600 58,407 52,091 -102,594 -32.26%
Tax 500 3,600 1,500 4,600 4,618 753 -479 -
NP -57,600 79,600 37,400 34,000 53,789 51,338 -102,115 -31.66%
Tax Rate - -4.33% -3.86% -11.92% -7.91% -1.45% - -
Total Cost 316,100 222,800 199,700 210,100 168,305 132,242 240,518 19.92%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -22.28 26.32 15.77 13.93 24.22 27.96 -73.78 -54.89%
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -0.62 0.86 0.40 0.37 0.59 0.56 -1.12 -32.50%
EPS Diluted -0.62 0.81 0.39 0.35 0.56 0.54 -1.12 -32.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.